wiseguyreports January 14, 2021

Market Research Future (MRFR) has launched a new release on the Prostate Cancer Market Research Report – Global Forecast till 2025. The report delivers a thorough understanding of the market’s present status and likely future growth trajectory over the forecast period.

The global Prostate Cancer Diagnostics Market size was valued at USD 10 billion in 2018 and is expected to exhibit a strong 7.1% CAGR over the forecast period between 2018 and 2025, according to the latest research report from Market Research Future (MRFR). The global prostate cancer market is expected to be driven mostly by the growing awareness about prostate cancer and the increasing entry of effective prostate cancer medication, according to MRFR.

ALSO READ : https://futurehealthcareresearch.hpage.com/prostate-cancer-diagnostics-market-analysis-2020.html

Segmentation:

The global prostate cancer market is segmented on the basis of treatment, end user, and region.

By treatment, the global prostate cancer market is segmented into surgery and medication. The medication segment is further sub-segmented into chemotherapy, targeted therapy, immunotherapy, hormone therapy, monoclonal antibodies, and others.

ALSO READ : https://healthcareresearch.exblog.jp/240173024/

By end use, the global prostate cancer market is segmented into hospitals and specialty centers.

Regional Analysis:

The Americas is the largest regional market for prostate cancer, followed by Europe. The widespread awareness about prostate cancer in North America has been a vital driver for the global prostate cancer market. According to the American Cancer Society, prostate cancer is the most common type of cancer among American men, and over 160,000 new cases were registered in 2018. The high geriatric population in North America and Europe is also a major driver for the global prostate cancer market.

ALSO READ : https://www.medgadget.com/2020/07/growing-threat-of-covid-19-to-drive-clinical-trials-market-global-size-estimation-industry-share-2020-technology-trends-new-development-pipeline-top-companies-merger-cagr-value.html

Prostate Cancer Market – Competitive Landscape

Highly competitive, the prostate cancer market appears to be fragmented due to the presence of several notable players. To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. Due to the increasing strategic partnerships, the structure of the market is changing rapidly. Besides, the growing competition in the market is encouraging multinational companies to acquire small yet promising companies operating in the developing markets.

Major Players

Players leading the global prostate cancer market include Bayer Pharma AG (Berlin), OncoGenex Pharmaceuticals Inc. (US), Progenics Pharmaceuticals, Inc. (US), OncBioMune Pharmaceuticals Inc. (US), TOLMAR Inc. (US), Endo Pharmaceuticals Inc., and Tokai Pharmaceuticals, Inc., among others.

ALSO READ : http://www.marketwatch.com/story/pharmacovigilance-market-size-2021-global-industry-analysis-growth-opportunities-top-company-profile-regional-revenue-forecast-to-2025-2021-01-08

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

https://mmcthemonitor.com/